IL-2-based Immunotherapy After Autologous Transplantation for Lymphoma and Breast Cancer Induces Immune Activation and Cytokine Release: A Phase I/Ii Trial
Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1704086
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2003
Authors
Publisher
Springer Science and Business Media LLC